A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Taspoglutide | Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist (EC50 = 0.06 nM) under investigation for treatment of type 2 diabetes. Synonyms: (N-((N-(L-histidyl)-2-aminoisobutyryl)-L-alpha-glutamyl-glycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamyl-glycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-lysyl)-2-aminoisobutyryl)-L-argininamide; H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Aib-Arg-NH2. CAS No. 275371-94-3. Molecular formula: C152H232N40O45. Mole weight: 3339.71. |  |
| Taspoglutide | Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist developed for treatment of type 2 diabetes, with an EC50 value of 0.06 nM. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ITM077; R1583; BIM51077. CAS No. 275371-94-3. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P0165. |  |
| Tasquinimod | Tasquinimod is an oral antiangiogenic agent, which has the potential for castration-resistant prostate cancer treatment. Tasquinimod binds to the regulatory Zn2+ binding domain of HDAC4 with Kd of 10-30 nM. Tasquinimod also is a S100A9 inhibitor[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ABR-215050. CAS No. 254964-60-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10528. | |
| TAT | TAT is a TAT peptide encoded by HIV-1 virus, which can increase the yields and solubility of heterologous proteins. Synonyms: Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2; (2S)-2-[(2S,8S,11S,14S,17S,20S)-2-Amino-11,14-bis(4-aminobutyl)-21-{[(1S)-1-{N-[(2S)-5-carbamimidamido-1-{[(2S)-5-carbamimidamido-1-{[(2S)-5-carbamimidamido-1-hydroxy-1-imino-2-pentanyl]imino}-1-hydroxy-2-pentanyl]imino}-1-hydroxy-2-pentanyl]imidic acid}-3-imidicacidpropyl]imino}-8,17,20-tris(3-carbamimidamidopropyl)-3,6,9,12,15,18,21-heptahydroxy-1-(4-hydroxyphenyl)-4,7,10,13,16,19-hexaazahenicosa-3,6,9,12,15,18-hexaen-yl]-N1-[(2S)-5-carbamimidamido-1-{[(2S)-5-carbamimidamido-1-{[(2S)-5-carbamimidamido-1-hydroxy-1-imino-2-pentanyl]imino}-1-hydroxy-2-pentanyl]imino}-1-hydroxy-2-pentanyl]pentanediimidic acid; L-tyrosyl-glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-argininamide. Grade: ≥95% by HPLC. CAS No. 697226-52-1. Molecular formula: C64H119N33O13. Mole weight: 1558.85. | |
| TAT | TAT (YGRKKRRQRRR) is derived from the transactivator of transcription (TAT) of human immunodeficiency virus-1 (HIV-1) and is a cell-penetrating peptide. TAT can increase the yields and the solubility of heterologous proteins[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: TAT(47-57); HIV-1 TAT protein (47-57). CAS No. 191936-91-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P0281. | |
| TAT 14 | TAT 14. Group: Biochemicals. Grades: Purified. CAS No. 1362661-34-4. Pack Sizes: 1mg. US Biological Life Sciences. |  Worldwide |
| TAT 14 | TAT 14 is an Nrf2 activator and inhibits Nrf2/Keap1 interaction with neuroprotective activity. TAT 14 has been shown to induce upregulation of Nrf2 pathway downstream gene expression including heme-oxygenase 1 and suppress LPS-induced TNF-α expression in THP-1 cells. Synonyms: TAT14; TAT-14; H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Leu-Gln-Leu-Asp-Glu-Glu-Thr-Gly-Glu-Phe-Leu-Pro-Ile-Gln-OH; L-tyrosyl-glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-leucyl-L-glutaminyl-L-leucyl-L-alpha-aspartyl-L-alpha-glutamyl-L-alpha-glutamyl-L-threonyl-glycyl-L-alpha-glutamyl-L-phenylalanyl-L-leucyl-L-prolyl-L-isoleucyl-L-glutamine; TAT 14 Peptide (Nrf2 Activator III). Grade: ≥95%. CAS No. 1362661-34-4. Molecular formula: C137H230N48O39. Mole weight: 3173.59. | |
| TAT 2-4 | TAT 2-4 is a peptide derived from the HIV-1 transactivator of transcription (Tat) protein. Synonyms: Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly; L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycine. Grade: ≥95%. CAS No. 1159916-66-1. Molecular formula: C132H240N66O29. Mole weight: 3215.74. | |
| TAT (47-57), FAM-labeled | It is a fluorescent (FAM) labeled TAT peptide, Abs/Em=494/521 nm. TAT is the most characteristic fragment of HIV trans-activator protein (TAT). The arginine-rich TAT peptide penetrates the plasma membrane directly rather than through endocytosis. Synonyms: FAM-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH; N-[(3',6'-Dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthen]-5-yl)carbonyl]-L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginine; 5-FAM-HIV-1 Tat Protein (47-57). Grade: ≥95%. CAS No. 1676104-81-6. Molecular formula: C85H128N32O20. Mole weight: 1918.16. | |
| TAT (47-57) GGG-Cys(Npys) | It corresponds to the protein transduction domain of the TAT protein and is synthesized with an activated cysteine residue C(Npys), where Npys is 3-Nitro-2-pyridinesulfenyl group and is used for activating S of cysteine and for rapid reaction when a thiol group is introduced. The N-terminus is rendered free for applications requiring certain conjugation reactions with a free N-terminal end, and a linker GGG is placed at the C-terminal end, and the peptide has been synthesized with the C(Npys) group. This kind of modification has been used to render this peptide as a cell penetrating and carrier peptide applicable in conjugation studies. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Gly-Cys(Npys)-NH2. Grade: ≥95%. Molecular formula: C78H135N39O19S2. Mole weight: 1987.29. | |
| TAT (47-57), TAMRA-labeled | It is a fluorescent (TAMRA)-labeled TAT peptide, Abs/Em=541/568 nm. TAT is the most characteristic fragment of HIV trans-activator protein (TAT). The arginine-rich TAT peptide penetrates the plasma membrane directly rather than through endocytosis. Synonyms: TAMRA-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH. Grade: ≥95%. | |
| TAT 48-57 | It is a cell-permeable peptide, derived from HIV-1 transactivator of transcription (Tat) protein residues 48-57. Synonyms: H-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH; glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginine; Tat protein (48-57); TAT (48-57). Grade: ≥95%. CAS No. 253141-50-3. Molecular formula: C55H109N31O12. Mole weight: 1396.65. | |
| TAT (48-57) TFA | It is a cell-permeable peptide, derived from HIV-1 transactivator of transcription (Tat) protein residues 48-57. Synonyms: Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg.TFA; glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginine; Tat protein (48-57). Grade: >98%. Molecular formula: C55H109N31O12.C2HF3O2. Mole weight: 1510.67. | |
| TATA (1,3,5-Triacryloylhexahydro-1,3,5-triazine) (CAS 959-52-4) | TATA (1,3,5-Triacryloylhexahydro-1,3,5-triazine) (CAS 959-52-4). CAS No. 959-52-4. Cenik is your partner of choice for specialised chemicals. We don't just provide products - we supply solutions to your technical and regulatory specifications. |  |
| TAT-amide | TAT-amide is a cell penetrating peptide. Cell-penetrating peptides (CPPs) are short amino acid sequences able to enter different cells[1][2]. Uses: Scientific research. Category: Peptides. CAS No. 697226-52-1. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P2193. | |
| Tat-beclin 1 | Tat-beclin 1, a peptide derived from a region of the autophagy protein (beclin 1), is a potent inducer of autophagy and interacts with negative regulator of autophagy, GAPR-1 (GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens (including HIV-1) in vitro, and reduces mortality in mice infected with chikungunya (CHIKV) or West Nile virus (WNV)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1423821-88-8. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-P2260. | |
| Tat-Beclin-1 | Beclin-1 peptide is the HIV-1 Nef binding portion of full-length human Beclin-1 protein (amino acids 267-299). Beclin-1 protein is an autophagy inducing agent that triggers cell adaptation, survival, or death. When combined with the cell-permeable peptide, it can successfully enter cells and induce autophagy. Synonyms: Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Thr-Asn-Val-Phe-Asn-Ala-Thr-Phe-Glu-Ile-Trp-His-Asp-Gly-Glu-Phe-Gly-Thr-OH; Tat-BECN1. Grade: ≥95%. Molecular formula: C164H251N57O45. Mole weight: 3741.15. | |
| Tat-Beclin-1, scrambled | Beclin-1 peptide is the HIV-1 Nef binding portion of full-length human Beclin-1 protein (amino acids 267-299). Beclin-1 protein is an autophagy inducing agent that triggers cell adaptation, survival, or death. When combined with the cell-permeable peptide, it can successfully enter cells and induce autophagy. Tat-Beclin-1, scrambled will not induce autophagy and can be used as a negative control. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Val-Gly-Asn-Asp-Phe-Phe-Ile-Asn-His-Glu-Thr-Thr-Gly-Phe-Ala-Thr-Glu-Trp-OH. Grade: ≥95% by HPLC. Molecular formula: C164H251N57O45. Mole weight: 3741.15. | |
| TAT-C (48-57) | It is amino acids 48 to 57 fragment of TAT with an additional cysteine residue at the N-terminus. The peptide contains a protein transduction domain (PTD) that inhibits HSV-1 entry into the HIV Tat protein. The addition of cysteine residue to the N-terminus of the Tat-PTD (Tat-C peptide) improves the antiviral activity against HSV-1 and HSV-2. Tat-C acts extracellular and immediately blocks the entry of adsorptive virus without eluting virions. Synonyms: H-Cys-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH; (Cys47)-HIV-1 tat Protein (47-57); L-cysteinyl-glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginine. Grade: ≥95%. CAS No. 627079-23-6. Molecular formula: C58H114N32O13S. Mole weight: 1499.82. | |
| TAT-cyclo-CLLFVY | TAT-cyclo-CLLFVY is a cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. TAT-cyclo-CLLFVY disrupts HIF-1α/HIF-1β protein-protein interaction with an IC50 of 1.3 μM[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1446322-66-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P1420. | |
| TAT-cyclo-CLLFVY | TAT-cyclo-CLLFVY has been found to be a HIF-1 dimerization inhibitor and could block protein-protein interaction of recombinant HIF-1α. Synonyms: TAT-cyclo-CLLFVY; 1446322-66-2; AKOS027470216; PD079835. Grade: ≥95% by HPLC. CAS No. 1446322-66-2. Molecular formula: C111H188N42O24S2. Mole weight: 2559.10. | |
| TAT-EE3 | TAT-EE3 is a neuroprotective peptide which can uncouple TRPM2-NMDARs interaction. TAT-EE3 inhibits TRPM2-induced enhancement of NMDAR surface expression and current amplitude.TAT-EE3 protects neurons against ischemic injury in vitro and in vivo. TAT-EE3can be used for the study of ischemic stroke[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2899218-49-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P11117. | |
| TAT-Gap19 | TAT-Gap19 is a brain penetrating Cx43 hemichannel blocker (IC50 ~7 μM) with no significant affinity for gap junctions or Panx1 channels. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Gln-Ile-Glu-Ile-Lys-Lys-Phe-Lys-OH; L-tyrosyl-glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-glutaminyl-L-isoleucyl-L-alpha-glutamyl-L-isoleucyl-L-lysyl-L-lysyl-L-phenylalanyl-L-lysine. Grade: 97%. CAS No. 1507930-54-2. Molecular formula: C119H212N46O26. Mole weight: 2703.28. | |
| TAT-Gap19 | TAT-Gap19, a Cx mimetic peptide, is a specific connexin43 hemichannel (Cx43 HC) inhibitor. TAT-Gap19 does not inhibits the corresponding Cx43 GJCs. TAT-Gap19 traverses the blood-brain barrier and alleviate liver fibrosis in mice[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1507930-54-2. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P1136B. | |
| TAT-GluA2 3Y | TAT-GluA2 3Y is a blood-brain barrier-permeable AMPA receptor inhibitory peptide that crosses cell membranes via the HIV-1 TAT protein domain. TAT-GluA2 3Y blocks the endocytosis of AMPA receptors, including the internalization of GluA1/GluA2 subunits, by disrupting interactions with the AP2, Brag2 and Syt3-GluA2 complexes, while also inhibiting long-term depression. TAT-GluA2 3Y blocks hypoxia-mediated AMPAR internalization, alleviates A1R-induced persistent synaptic inhibition, and reduces cerebral ischemic volume, neurological deficits and spatial memory deficits. TAT-GluA2 3Y blocks the effect of NLRP3 deficiency on fear generalization, inhibits amphetamine-induced behavioral/neurochemical sensitization, weakens the unconditioned stimulus-conditioned stimulus association of morphine, and promotes the extinction of morphine CPP. TAT-GluA2 3Y can be used in studies related to fear generalization, ischemic stroke, hypoxia, drug addiction and opioid addiction[1][2][3][4][5]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1404188-93-7. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P2259. | |
| TAT-GluA2 3Y acetate | TAT-GluA2 3Y acetate is a cell-penetrating peptide containing tyrosine residues. It inhibits the phosphorylation of alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) receptor endocytosis. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Tyr-Lys-Glu-Gly-Tyr-Asn-Val-Tyr-Gly-OH.CH3CO2H; L-tyrosyl-glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-tyrosyl-L-lysyl-L-alpha-glutamyl-glycyl-L-tyrosyl-L-asparagyl-L-valyl-L-tyrosyl-glycine acetic acid. Grade: ≥95%. Molecular formula: C117H189N43O31. Mole weight: 2694.07. | |
| TAT-GluR23A Fusion Peptide | TAT-GluR23A Fusion Peptide is a control inactive peptide that acts as a mutant counterpart to glutamate receptor endocytosis inhibitor (GluR23Y), linked to an 11 amino acid cell permeable HIV Trans-activator of Transcription (TAT) protein transduction domain (PTD). GluR23A is derived from GluR23Y amino acid 869-877, which is substituted for Tyr by Ala and lacks necessary phosphorylation sites. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Ala-Lys-Glu-Gly-Ala-Asn-Val-Ala-Gly-OH. Grade: ≥95%. Molecular formula: C97H173N43O26. Mole weight: 2357.71. | |
| TAT-GluR23Y | TAT-GluR23Y is a cell penetrating peptide containing tyrosine residues. It inhibits the phosphorylation of alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) receptor endocytosis. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Tyr-Lys-Glu-Gly-Tyr-Asn-Val-Tyr-Gly-OH; Tat-GluR23Y; L-tyrosyl-glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-tyrosyl-L-lysyl-L-alpha-glutamyl-glycyl-L-tyrosyl-L-asparagyl-L-valyl-L-tyrosyl-glycine; TAT-GluA2 3Y. Grade: ≥95%. CAS No. 1404188-93-7. Molecular formula: C115H185N43O29. Mole weight: 2634.01. | |
| TAT-GluR23Y, scrambled | TAT-GluR23Y, scrambled is a control peptide. The synthetic peptide (Tat-Glur23Y), containing tyrosine residues, blocks phosphorylation of AMPA receptor endocytosis. However, the scrambled version does not have blockade properties. Previous studies show that Tat-Glur23Y, scrambled increases stress levels in mice, while Tat-Glur23Y reduces stress when administered. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Val-Tyr-Lys-Tyr-Gly-Gly-Tyr-Asn-Glu-OH; Tat-GluR23Y, scrambled. Grade: ≥95%. Molecular formula: C115H185N43O29. Mole weight: 2634.01. | |
| TAT-HA2 Fusion Peptide | It is a cell penetrating peptide consisting of amino acids 1 to 20 of influenza A virus hemagglutinin protein (HA2), which is linked to a 10 amino acid cell permeable HIV Trans-activator of Transcription (TAT) protein transduction domain (PTD). TAT-HA2 can be used as a large molecule drug delivery peptide. TAT PTD binds to the cell surface and penetrates the cell membrane through lipid raft dependent macropinocytosis. The HA2 domain is a pH-sensitive lipid membrane destabilizing sequence that enhances endosomal escape and transduction of the fusion peptide. Synonyms: H-Arg-Arg-Arg-Gln-Arg-Arg-Lys-Lys-Arg-Gly-Gly-Asp-Ile-Met-Gly-Glu-Trp-Gly-Asn-Glu-Ile-Phe-Gly-Ala-Ile-Ala-Gly-Phe-Leu-Gly-OH. Grade: ≥95%. Molecular formula: C149H243N53O39S. Mole weight: 3432.98. | |
| TAT-HA2 Fusion Peptide | TAT-HA2 Fusion Peptide is a peptide-based delivery agent that combines the pH-sensitive HA2 fusion peptide from Influenza and the cell-penetrating peptide TAT from HIV. TAT-HA2 Fusion Peptide is a transactivator of transcription and hemaglutanin for endosomal release. TAT-HA2 Fusion Peptide enhances cellular uptake of macromolecules[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 923954-79-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P4108. | |
| TAT-M2NX | TAT-M2NX (tatM2NX) is a selective inhibitor targeting human TRPM2 channels and exerts inhibitory effects on ischemic stroke. TAT-M2NX reduces H2O2-induced calcium influx via TRPM2 channels. After traumatic brain injury in mice, TAT-M2NX preserves hippocampal long-term potentiation, improves memory function, and reduces infarct volume after middle cerebral artery occlusion, but it shows no effect on female mice. TAT-M2NX can be used in studies related to traumatic brain injury and ischemic stroke[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: tatM2NX. CAS No. 2126166-03-6. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P5883. | |
| Tat-NR2B9c | Tat-NR2B9c (Tat-NR2Bct; NA-1) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy[1][2][5]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Tat-NR2Bct; NA-1. CAS No. 500992-11-0. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P0117. | |
| TAT-NR2B9c | Tat-NR2B9c (NA-1) is a membrane-permeable postsynaptic density-95 (PSD-95)-binding (decoy) peptide and a neuroprotective agent that can inhibit neuronal excitotoxicity. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Leu-Ser-Ser-Ile-Glu-Ser-Asp-Val-OH; Tat-NR2Bct; Tat-NR2B9c; NA-1; L-tyrosyl-glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-seryl-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-seryl-L-alpha-aspartyl-L-valine; Nerinetide. Grade: ≥95%. CAS No. 500992-11-0. Molecular formula: C105H188N42O30. Mole weight: 2518.92. | |
| Tat-NR2B9c TFA | Tat-NR2B9c TFA (Tat-NR2Bct TFA) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c TFA disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c TFA also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Tat-NR2Bct TFA; NA-1 TFA. CAS No. 1834571-04-8. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-P0117A. | |
| Tat-NR2B9c TFA | Tat-NR2B9c TFA is a membrane-permeable postsynaptic density-95 (PSD-95)-binding (decoy) peptide and a neuroprotective agent that can inhibit neuronal excitotoxicity. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Leu-Ser-Ser-Ile-Glu-Ser-Asp-Val-OH.TFA; L-tyrosyl-glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-seryl-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-seryl-L-alpha-aspartyl-L-valine trifluoroacetic acid; NA-1 TFA. CAS No. 1834571-04-8. Molecular formula: C107H189F3N42O32. Mole weight: 2632.9. | |
| TAT-NSF222 Fusion Peptide | This sequence is a N-ethylmaleimide sensitive factor (NSF) peptide that connects to the 11 amino acid cell permeable human immunodeficiency virus (HIV) transactivating regulatory protein (TAT) domain by Gly-Gly-Gly spacer. The peptide contains the NSF domain extending from 222 to 243 amino acids, which is located directly at the amino terminus of the Walker A motif in the NSF D1 domain. ATPase assay shows that TAT-NSF222 inhibits the activity of NSF ATPase. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Gly-Leu-Asp-Lys-Glu-Phe-Asn-Ser-Ile-Phe-Arg-Arg-Ala-Phe-Ala-Ser-Arg-Val-Phe-Pro-Pro-Glu-OH. Grade: ≥95%. Molecular formula: C187H301N67O47. Mole weight: 4239.89. | |
| TAT-NSF222scr Fusion Polypeptide, scrambled | It is a scrambled TAT-NSF222scr fusion polypeptide. It consists of 11 amino acids from the cell permeable human immunodeficiency virus TAT polypeptide, 3 glycines as a linker, followed by scrambled N-Ethyl-maleimide-sensitive factor (NSF) D1 domain. It is used as a control for the TAT-NSF222 peptide. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Gly-Glu-Asn-Ser-Phe-Arg-Phe-Leu-Ala-Asp-Ile-Phe-Pro-Ala-Lys-Ala-Phe-Pro-Val-Arg-Phe-Glu-OH. Grade: ≥95%. Molecular formula: C190H298N64O46. Mole weight: 4214.88. | |
| TAT-NSF700 Fusion Peptide | It is a N-Ethyl-maleimide-sensitive factor (NSF) inhibitor fusion polypeptide, which is fused from the 11 amino acid cell permeable HIV transactivation regulatory protein (TAT) domain to the 22 amino acid NSF domain. TAT-NSF700 inhibits thrombin-induced exocytosis of endothelial cells in a dose-responsive manner. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Gly-Leu-Leu-Asp-Tyr-Val-Pro-Ile-Gly-Pro-Arg-Phe-Ser-Asn-Leu-Val-Leu-Gln-Ala-Leu-Leu-Val-Leu-OH; L-tyrosyl-glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-glycyl-glycyl-glycyl-L-leucyl-L-leucyl-L-alpha-aspartyl-L-tyrosyl-L-valyl-L-prolyl-L-isoleucyl-glycyl-L-prolyl-L-arginyl-L-phenylalanyl-L-seryl-L-asparagyl-L-leucyl-L-valyl-L-leucyl-L-glutaminyl-L-alanyl-L-leucyl-L-leucyl-L-valyl-L-leucine. Grade: ≥95%. Molecular formula: C188H318N62O45. Mole weight: 4167.00. | |
| TAT-NSF700scr | TAT-NSF700scr is used as a control peptide to TAT-NSF700 peptide. Compared with TAT-NSF700, it does not inhibit the disassembly activity of NSF, and TAT-NSF700 plays a key role in regulating exocytosis. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Gly-Ile-Pro-Pro-Val-Tyr-Phe-Ser-Arg-Leu-Asp-Leu-Asn-Leu-Val-Val-Leu-Leu-Leu-Ala-Gln-Leu-OH. Grade: ≥95%. Molecular formula: C186H315N61O44. Mole weight: 4109.95. | |
| TAT-NSF81scr Fusion Polypeptide, scrambled | It is a scrambled peptide containing the TAT domain and 20 of N-Ethyl-maleimide-sensitive factor 81 (NSF81). TAT-NSF81scr is used to measure the effect of the active and control peptides upon NSF activities and exocytosis. Synonyms: H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Gly-Gln-Asp-Gly-Cys-Lys-Tyr-Phe-Ala-Thr-Asp-Glu-Thr-Ile-Met-Lys-Leu-Ser-Ile-Ala-Ile-OH. Grade: ≥97%. Molecular formula: C169H284N58O48S2. Mole weight: 3960.61. | |
| TAT-P110 | TAT-P110, a peptide inhibitor of Drp1-Fis1 interaction, reduces pathology in numerous models of neurodegeneration, ischemia, and sepsis without blocking the physiological functions of Drp1[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: P110. CAS No. 2247617-97-4. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P2280. | |
| TAT P59W | It is a TAT peptide containing tryptophane residues. Synonyms: Fluo-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Pro-Trp-Gln-NH2. Grade: 98%. | |
| TAT peptide | TAT peptide, derived from the transactivator of transcription (TAT) of human immunodeficiency virus, is a cell penetrating peptide (GRKKRRQRRRPQ). Synonyms: TAT-peptide. Grade: 98%. Molecular formula: C65H124N34O15. Mole weight: 1621.91. | |
| TAT-PiET-PROTAC | TAT-PiET-PROTAC is a proteolysis-targeting chimera (PROTAC)-modified TAT-PiET (HY-P10445), which is a cell-penetrating peptide targeting the extra-terminal (ET) domain of BRD4. TAT-PiET-PROTAC can reduce BRD4 and JMJD6 levels and inhibit cell proliferation. TAT-PiET-PROTAC also resists the endocrine resistance of ERα-positive breast cancer cells. TAT-PiET-PROTAC can be used for the research of cancer, such as breast cancer[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3036046-04-2. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-P10446. | |
| Tatsinine | Tatsinine is a potential natural compound in natural compound used for the research of various cancers. With its unique chemical structure, it has shown promising anti-tumor activity by inhibiting specific signaling pathways involved in cancer progression. Synonyms: 20-ethyl-16-methoxy-4-methylaconitane-1,7,8,9,14-pentol. Grade: 97.0%. CAS No. 90038-21-4. Molecular formula: C22H35NO6. Mole weight: 409.523. | |
| TATU | TATU. Synonyms: O-(7-Azabenzotriazole-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; 2-(3H-[1,2,3]Triazolo[4,5-b]pyridin-3-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate; 2-(7-Azabenzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate; O-(7-Azabenzotriazolyl)-tetramethyluronium tetrafluoroborate; TATU [O-(7-Azabenzotriazole-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate]; ACMC-209vlk; SCHEMBL153586. Grade: 99% (HPLC). CAS No. 873798-09-5. Molecular formula: C10H16BF4N6O. Mole weight: 323.08. | |
| TATU | TATU. Group: Biochemicals. Alternative Names: 1-[Bis (dimethylamino) methylene]-1H-1, 2, 3-triazolo[4, 5-b]pyridinium 3-oxide tetrafluoroborate; O-(7-Azabenzotriazole-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate. Grades: Highly Purified. CAS No. 873798-09-5,873678-56-9. Pack Sizes: 50g, 100g, 250g, 500g, 1kg. Molecular Formula: C10H15N6OBF4. US Biological Life Sciences. | Worldwide |
| TAU-IN-1 | TAU-IN-1 (compound 051) is a TAU protein inhibitor with an EC50 value of 325 nM. TAU-IN-1 can be used in the study of neurodegenerative diseases[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1383373-65-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-13486. | |
| TAU-IN-4 | TAU-IN-4 (compound I1.21) is a potent Tau aggregation inhibitor with a KD of 1.58 μM. TAU-IN-4 can be used in the study of Alzheimers disease[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2109305-45-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-172973. | |
| TAU-IN-5 | TAU-IN-5 (compound 13) is a TAU protein inhibitor with an EC50 of 0.81 μM. TAU-IN-5 inhibits the formation of tau (2N4R isoform) oligomers and reduces the formation of tau dimers. TAU-IN-5 can be used in the study of Alzheimer's disease (AD) and Parkinson's disease (PD)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3118812-61-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-175840. | |
| Tau ligand-1 | Tau ligand-1 (Compound 75) is a ligand for aggregated tau protein that can penetrate the blood-brain barrier[1]. In tissues from patients with Alzheimer's disease, progressive supranuclear palsy, corticobasal degeneration, and Pick's disease, Tau ligand-1 exhibits high affinity for aggregated tau protein, with equilibrium dissociation constant (KD) values ranging from 1 to 3.8 nM[1]. Tau ligand-1 can serve as a potential positron emission tomography (PET) tracer and holds promise for application in positron emission tomography imaging studies of tau-related diseases in the central nervous system[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3063166-64-0. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-173291. | |
| Tau Peptide (1-16) (human) | Tau peptide (1-16) (human) corresponds to the N-terminus of the nascent Tau protein. Posttranslational modifications include removal of N-terminal Met and acetylation of Ala2. Synonyms: H-Met-Ala-Glu-Pro-Arg-Gln-Glu-Phe-Glu-Val-Met-Glu-Asp-Met-Ala-Gly-OH. Grade: ≥95%. CAS No. 2022956-53-0. Molecular formula: C77H120N20O28S3. Mole weight: 1870.12. | |
| Tau Peptide (244-274) (Repeat 1 Domain) | During heparin-induced self-aggregation of the four repeat domain peptides (R1-R4) excised from tau, R1, which is similar to the Tau peptide (244-274), shows the strongest resistance to filament formation. Its conformation remains the same. It maintains the same random structure under acidic and neutral conditions. Synonyms: H-Gln-Thr-Ala-Pro-Val-Pro-Met-Pro-Asp-Leu-Lys-Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys-His-Gln-Pro-Gly-Gly-Gly-Lys-OH; L-Glutaminyl-L-threonyl-L-alanyl-L-prolyl-L-valyl-L-prolyl-L-methionyl-L-prolyl-L-alpha-aspartyl-L-leucyl-L-lysyl-L-asparaginyl-L-valyl-L-lysyl-L-seryl-L-lysyl-L-isoleucylglycyl-L-seryl-L-threonyl-L-alpha-glutamyl-L-asparaginyl-L-leucyl-L-lysyl-L-histidyl-L-glutaminyl-L-prolylglycylglycylglycyl-L-lysine. Grade: ≥95%. CAS No. 330456-24-1. Molecular formula: C141H238N42O44S. Mole weight: 3257.63. | |
| Tau Peptide (245-274) (Repeat 1 Domain) | Tau Peptide (245-274) (Repeat 1 Domain). Synonyms: H-Thr-Ala-Pro-Val-Pro-Met-Pro-Asp-Leu-Lys-Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys-His-Gln-Pro-Gly-Gly-Gly-Lys-OH; L-threonyl-L-alanyl-L-prolyl-L-valyl-L-prolyl-L-methionyl-L-prolyl-L-alpha-aspartyl-L-leucyl-L-lysyl-L-asparagyl-L-valyl-L-lysyl-L-seryl-L-lysyl-L-isoleucyl-glycyl-L-seryl-L-threonyl-L-alpha-glutamyl-L-asparagyl-L-leucyl-L-lysyl-L-histidyl-L-glutaminyl-L-prolyl-glycyl-glycyl-glycyl-L-lysine. Grade: ≥95%. CAS No. 1428134-39-7. Molecular formula: C136H230N40O42S. Mole weight: 3129.63. | |
| Tau Peptide (255-314) (Repeat 2 Domain) (human) | Tau Peptide (255-314) (Repeat 2 Domain) (human). Synonyms: H-Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys-His-Gln-Pro-Gly-Gly-Gly-Lys-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-Ser-Asn-Val-Gln-Ser-Lys-Cys-Gly-Ser-Lys-Asp-Asn-Ile-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-OH. Grade: ≥95%. CAS No. 2022995-68-0. Molecular formula: C277H467N83O86S. Mole weight: 6368.33. | |
| Tau Peptide (255-314) (Repeat 2 Domain) (human) | Tau Peptide (255-314) (Repeat 2 Domain) (human) (Tau-F protein (255-314)) is a polypeptide. Tau Peptide (255-314) (human) is the 255-314 fragment of Tau-F (also known as Tau-4, the 2N4 isoform), a major isoform of the Tau protein. Tau Peptide (255-314) (human) contains two core driving sequences for Tau aggregation, namely PHF6* (275-280, VQIINK) and PHF6 (306-311, VQIVYK), and spans the C-terminal half of repeat domain R1, the entire repeat domain R2, and the N-terminal half of repeat domain R3 within the microtubule-binding region (MTBR). Uses: Scientific research. Category: Signaling pathways. Alternative Names: Tau-F protein (255-314). CAS No. 2022995-68-0. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P4933. | |
| Tau Peptide (268-282) | Tau Peptide (268-282). Synonyms: H-His-Gln-Pro-Gly-Gly-Gly-Lys-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-OH; L-Histidyl-L-glutaminyl-L-prolylglycylglycylglycyl-L-lysyl-L-valyl-L-glutaminyl-L-isoleucyl-L-isoleucyl-L-asparaginyl-L-lysyl-L-lysyl-L-leucine. Grade: ≥95%. CAS No. 330456-37-6. Molecular formula: C72H125N23O19. Mole weight: 1616.93. | |
| Tau Peptide (273-284) | Tau Peptide (273-284), a Tau fragment containing the PHF6 region, plays a central role in Tau aggregation. Synonyms: H-Gly-Lys-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-OH; glycyl-L-lysyl-L-valyl-L-glutaminyl-L-isoleucyl-L-isoleucyl-L-asparagyl-L-lysyl-L-lysyl-L-leucyl-L-alpha-aspartyl-L-leucine. Grade: ≥95%. CAS No. 1663490-91-2. Molecular formula: C62H113N17O17. Mole weight: 1368.68. | |
| Tau Peptide (274-288) | Tau Peptide (274-288). Synonyms: H-Lys-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-Ser-Asn-Val-Gln-OH; L-Lysyl-L-valyl-L-glutaminyl-L-isoleucyl-L-isoleucyl-L-asparaginyl-L-lysyl-L-lysyl-L-leucyl-L-α-aspartyl-L-leucyl-L-seryl-L-asparaginyl-L-valyl-L-glutamine. Grade: ≥95%. CAS No. 330456-39-8. Molecular formula: C77H138N22O23. Mole weight: 1740.08. | |
| Tau Peptide (275-305) (Repeat 2 Domain) | Tau Peptide (275-305) (Repeat 2 Domain). Synonyms: H-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-Ser-Asn-Val-Gln-Ser-Lys-Cys-Gly-Ser-Lys-Asp-Asn-Ile-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-OH; L-Valyl-L-glutaminyl-L-isoleucyl-L-isoleucyl-L-asparaginyl-L-lysyl-L-lysyl-L-leucyl-L-α-aspartyl-L-leucyl-L-seryl-L-asparaginyl-L-valyl-L-glutaminyl-L-seryl-L-lysyl-L-cysteinylglycyl-L-seryl-L-lysyl-L-α-aspartyl-L-asparaginyl-L-isoleucyl-L-lysyl-L-histidyl-L-valyl-L-prolylglycylglycylglycyl-L-serine. Grade: ≥95%. CAS No. 330456-25-2. Molecular formula: C139H239N43O45S. Mole weight: 3264.76. | |
| Tau Peptide (277-291) | Tau Peptide (277-291). Synonyms: H-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-Ser-Asn-Val-Gln-Ser-Lys-Cys-OH; L-Isoleucyl-L-isoleucyl-L-asparaginyl-L-lysyl-L-lysyl-L-leucyl-L-α-aspartyl-L-leucyl-L-seryl-L-asparaginyl-L-valyl-L-glutaminyl-L-seryl-L-lysyl-L-cysteine. Grade: ≥95%. CAS No. 330456-40-1. Molecular formula: C73H131N21O23S. Mole weight: 1703.04. | |
| Tau Peptide (294-305) (human) | Tau 294-305, an anti-tau vaccine, conjugates to KLH via an N-terminal cysteine. Tau Peptide (294-305) (human) may prevent the formation of beta/beta-helix structure of protofilaments, including residues 306-378. Synonyms: Microtubule-Associated Protein Tau (610-621) (human); H-Lys-Asp-Asn-Ile-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-OH; L-Lysyl-L-α-aspartyl-L-asparaginyl-L-isoleucyl-L-lysyl-L-histidyl-L-valyl-L-prolylglycylglycylglycyl-L-serine. Grade: ≥95%. CAS No. 1428135-29-8. Molecular formula: C51H85N17O17. Mole weight: 1208.32. | |
| Tau Peptide (295-309) | Tau Peptide (295-309). Synonyms: H-Asp-Asn-Ile-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-Val-Gln-Ile-Val-OH; L-α-Aspartyl-L-asparaginyl-L-isoleucyl-L-lysyl-L-histidyl-L-valyl-L-prolylglycylglycylglycyl-L-seryl-L-valyl-L-glutaminyl-L-isoleucyl-L-valine. Grade: ≥95%. CAS No. 330456-46-7. Molecular formula: C66H110N20O21. Mole weight: 1519.72. | |
| Tau Peptide (298-312) | Tau Peptide (298-312). Synonyms: H-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-Val-Gln-Ile-Val-Tyr-Lys-Pro-OH; L-Lysyl-L-histidyl-L-valyl-L-prolylglycylglycylglycyl-L-seryl-L-valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysyl-L-proline. Grade: ≥95%. CAS No. 330456-47-8. Molecular formula: C72H116N20O19. Mole weight: 1565.84. | |
| Tau Peptide (301-315) | Tau Peptide (301-315). Synonyms: H-Pro-Gly-Gly-Gly-Ser-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-OH; L-Prolylglycylglycylglycyl-L-seryl-L-valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysyl-L-prolyl-L-valyl-L-α-aspartyl-L-leucine. Grade: ≥95%. CAS No. 330456-48-9. Molecular formula: C70H113N17O21. Mole weight: 1528.77. | |
| Tau Peptide (304-318) | Tau Peptide (304-318). Synonyms: H-Gly-Ser-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-Ser-Lys-Val-OH; Glycyl-L-seryl-L-valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysyl-L-prolyl-L-valyl-L-α-aspartyl-L-leucyl-L-seryl-L-lysyl-L-valine. Grade: ≥95%. CAS No. 330456-49-0. Molecular formula: C75H126N18O22. Mole weight: 1631.93. | |
| Tau Peptide (306-317) | Tau Peptide (306-317). Synonyms: H-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-Ser-Lys-OH; L-Valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysyl-L-prolyl-L-valyl-L-α-aspartyl-L-leucyl-L-seryl-L-lysine. Grade: ≥95%. CAS No. 1003007-59-7. Molecular formula: C65H109N15O18. Mole weight: 1388.67. | |
| Tau Peptide (306-336) (Repeat 3 Domain) | Tau Peptide (306-336) (Repeat 3 Domain), the amphipathic helical structure of the third fragment (306-336) of the four-repeat microtubule-binding domain of water-soluble Tau protein, may be involved in the formation of neuropathological filament. Synonyms: H-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-Ser-Lys-Val-Thr-Ser-Lys-Cys-Gly-Ser-Leu-Gly-Asn-Ile-His-His-Lys-Pro-Gly-Gly-Gly-Gln-OH; L-Glutamine, L-valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysyl-L-prolyl-L-valyl-L-α-aspartyl-L-leucyl-L-seryl-L-lysyl-L-valyl-L-threonyl-L-seryl-L-lysyl-L-cysteinylglycyl-L-seryl-L-leucylglycyl-L-asparaginyl-L-isoleucyl-L-histidyl-L-histidyl-L-lysyl-L-prolylglycylglycylglycyl-. Grade: ≥95%. CAS No. 330456-26-3. Molecular formula: C143H236N42O42S. Mole weight: 3247.77. | |
| Tau Peptide (306-336) (Repeat 3 Domain) | Tau Peptide (306-336) (Repeat 3 Domain) is aTau fragment. Uses: Scientific research. Category: Signaling pathways. CAS No. 330456-26-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P4966. | |
Our database is helping our users find suppliers everyday.
